| Company Name: | American Shared Hospital Services | | Ticker Symbol: | AMS | | | WWW Address: | www.ashs.com |
| CEO: | Dr. Ernest A. Bates,M.D. | | No. of Employees: | 10 |
| Common Issue Type: | CS | | Business Description: | American Shared Hospital Services provides Gamma Knife stereotactic radiosurgery equipment and radiation therapy and related equipment to nineteen medical centers in sixteen states in the United States and Turkey.
|
| | | Industry Information: | HEALTH SERVICES - Specialized Health Services [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 2.1 |  0.0 | - | - | 2.1 | 2.10 | 2.05 | 3186 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 9.7 | 4.6 | 1.16 | 0.01 | 0.00 | 210.0 | 0.0 | 3.55 - 1.52 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 2.10 | $ | | PE Ratio - LTM | 210.0 | |
| Market Capitalisation | 9.7 | mil |
| Latest Shares Outstanding | 4.6 | mil |
| Earnings pS (EPS) | 0.01 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | | % |
| Revenue per Employee | 1,704,800 | $ |
| Effective Tax Rate | 11.6 | % |
| Float | 3.4 | mil |
| Float as % of Shares Outstanding | 74.5 | % |
| Foreign Sales | | mil |
| Domestic Sales | | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 24.60 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 76.5 | % |
| EBITDA Margin | 51.9 | % |
| Pre-Tax Profit Margin | 5.6 | % |
| Assets Turnover | 0.2 | % |
| Return on Assets (ROA) | 1.5 | % |
| Return on Equity (ROE) | 5.3 | % |
| Return on Capital Invested (ROCI) | 2.0 | % |
| Current Ratio | 1.6 | |
| Leverage Ratio (Assets/Equity) | 3.6 | |
| Interest Cover | 1.6 | |
| Total Debt/Equity (Gearing Ratio) | 2.07 | |
| LT Debt/Total Capital | 63.0 | % |
| Working Capital pS | 1.27 | $ |
| Cash pS | 0.28 | $ |
| Book-Value pS | 4.34 | $ |
| Tangible Book-Value pS | 4.34 | $ |
| Cash Flow pS | 1.54 | $ |
| Free Cash Flow pS | 0.72 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 0.48 | |
| Price/Tangible Book Ratio | 0.48 | |
| Price/Cash Flow | 1.4 | |
| Price/Free Cash Flow | 2.9 | |
| P/E as % of Industry Group | 994.0 | % |
| P/E as % of Sector Segment | 751.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 7.6 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 1.4 | 103 | 302 | 1,161 |
| 4 Weeks | 2.17 | 1.52 | 1.65 | 27.1 | 122 | 164 | 3,284 |
| 13 Weeks | 2.17 | 1.52 | 2.11 | -0.5 | 91 | 111 | 7,103 |
| 26 Weeks | 2.84 | 1.52 | 2.64 | -20.5 | 68 | 109 | 13,646 |
| 52 Weeks | 3.55 | 1.52 | 3.09 | -32.0 | 54 | 79 | 19,581 |
| YTD | 2.81 | 1.52 | - | -23.1 | 67 | 125 | 12,463 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 2.00 | 1.91 | 1.80 | 2.22 | 2.42 | 1.16 | 0.21 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | -2.28 | 10.7 | 2.10 |
| Income | 0.00 | 0.0 | 0.00 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | -13.32 | NA | 125.93 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | 0.00 | NA | 0.00 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 6.0 | 6.0 | -23.3 |
| Earnings % | 2488.9 | 2488.9 | 60.7 |
| EPS % | 0.0 | 0.0 | -90.9 |
| EPS $ | 0.01 | 0.01 | -0.10 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 8.60 |
| Current Ratio | 1.7 |
| Quick Ratio (Acid Test) | 1.5 |
| Liquidity Ratio (Cash) | 1.10 |
| Receivables Turnover | 3.8 |
| Average Collection Period | 95 |
| Working Capital/Equity | 31.6 |
| Working Capital pS | 1.37 |
| Cash-Flow pS | 1.50 |
| Free Cash-Flow pS | -0.12 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 0.58 |
| Financial Leverage Ratio (Assets/Equity) | 3.7 |
| Debt Ratio | 72.8 |
| Total Debt/Equity (Gearing Ratio) | 2.17 |
| LT Debt/Equity | 1.78 |
| LT Debt/Capital Invested | 78.8 |
| LT Debt/Total Liabilities | 66.6 |
| Interest Cover | 1.4 |
| Interest/Capital Invested | 3.38 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 5.46 |
| Tobin's Q Ratio | 0.13 |
| Current P/E Ratio - LTM | 210.00 |
| Enterprise Value (EV)/EBITDA | 5.84 |
| Enterprise Value (EV)/Free Cash Flow | -29.66 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 0.48 |
| Price/Book Ratio - LTM | 0.48 |
| Price/Cash Flow Ratio | 1.4 |
| Price/Free Cash Flow Ratio - LTM | 2.9 |
| Price/Sales Ratio | 0.56 |
| P/E Ratio (1 month ago) - LTM | 166.0 |
| P/E Ratio (26 weeks ago) - LTM | 52.8 |
| P/E Ratio (52 weeks ago) - LTM | 30.9 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | |
| P/E as % of Industry Group | 994.0 |
| P/E as % of Sector Segment | 751.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 210.0 |
| PER SHARE FIGURES |
| LT Debt pS | 7.72 |
| Current Liabilities pS | 2.10 |
| Tangible Book Value pS - LTM | 4.34 |
| Book Value pS - LTM | 4.34 |
| Capital Invested pS | 12.05 |
| Cash pS - LTM | 0.28 |
| Cash Flow pS - LTM | 1.54 |
| Free Cash Flow pS - LTM | 0.72 |
| Earnings pS (EPS) | 0.01 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | -3.19 |
| Free Cash Flow Margin 5YEAR AVG | 19.72 |
| Net Profit Margin | 4.8 |
| Net Profit Margin - 5YEAR AVRG. | 1.8 |
| Equity Productivity | 0.86 |
| Return on Equity (ROE) | 4.1 |
| Return on Equity (ROE) - 5YEAR AVRG. | 1.7 |
| Capital Invested Productivity | 0.31 |
| Return on Capital Invested (ROCI) | 1.5 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 0.7 |
| Assets Productivity | 0.20 |
| Return on Assets (ROA) | 1.1 |
| Return on Assets (ROA) - 5YEAR AVRG. | 0.5 |
| Gross Profit Margin | 76.5 |
| Gross Profit Margin - 5YEAR AVRG. | 75.1 |
| EBITDA Margin - LTM | 51.9 |
| EBIT Margin - LTM | 17.4 |
| Pre-Tax Profit Margin | 5.4 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 6.7 |
| Effective Tax Rate | 11.6 |
| Effective Tax Rate - 5YEAR AVRG. | 20.8 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 87 |
| Revenue per Employee | 1,704,800 |
| Net Income per Employee | 81,300 |
| Average Collection Period | 87 |
| Receivables Turnover | 3.8 |
| Day's Inventory Turnover Ratio | |
| Inventory Turnover | 0.0 |
| Inventory/Sales | 0.0 |
| Accounts Payble/Sales | 1.54 |
| Assets/Revenue | 5.00 |
| Net Working Capital Turnover | 2.70 |
| Fixed Assets Turnover | 0.30 |
| Total Assets Turnover | 0.2 |
| Revenue per $ Cash | 10.90 |
| Revenue per $ Plant | 0.32 |
| Revenue per $ Common Equity | 0.86 |
| Revenue per $ Capital Invested | 0.31 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 23.7 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 22.8 |
| Research & Devlopment (R&D) as % of Revenue | 0.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
|
|  
|
| |
 |  |
